Skip to main content

Table 1 Significant investigations done throughout admission

From: Human herpesvirus-6 infection in a critically ill and immunocompetent patient: a case report

Biochemistry

Days of admission

1

2

5

7

12

18

21

28

Procalcitonin (µg/L)

62.2

28.6

94.2

14.4

0.88

NA

NA

NA

CRP (mg/L)

86.1

56.6

13.5

10.8

7.1

NA

11.4

NA

Ferritin (µg/L)

NA

98,870

NA

7410

NA

NA

590

NA

Hematology

 Hemoglobin (d/L)

9.9

9.9

9.0

7.1

9.1

10.9

10.1

10.9

 WBC count (× 109/L)

1.01

1.02

23.51

22.38

9.02

5.67

8.21

8.44

  Neutrophil (× 109/L)

0.56

0.40

25.50

15.33

8.28

4.09

6.99

5.93

  Lymphocyte (× 109/L)

0.26

0.52

18.95

1.52

0.49

0.84

0.81

1.98

 Platelets (× 109/L)

60

52

34

29

272

232

146

223

Coagulation

 PT (s)

NA

16.5

11.9

11.4

NA

11.3

11.1

10.6

 aPTT (s)

NA

118.4

37.3

27.3

26.6

30.9

33.5

29.0

 INR

NA

1.64

1.12

1.09

NA

1.08

1.06

1.01

Virology

 Cytomegalovirus (CMV, IU/mL)

NA

120 (2.08 log)

NA

NA

NA

NA

NA

NA

 HHV-6 PCR (copies/mL)

NA

NA

4,805,000 (6.68 log)

NA

63,425 (4.80 log)

43,000 (4.63 log)

96,825 (4.99 log)

42,400 (4.63 log)

  1. Not applicable (NA) indicates that the investigation was not repeated on the day; CRP C-reactive Peptide, WBC White Blood Cell, PT Prothrombin Time, aPTT Activated Partial Thromboplastin Time, INR International Normalised Ratio, HHV-6 PCR Human Herpesvirus-6 Polymerase Chain Reaction